NCT05613621View on ClinicalTrials.gov

Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies

Active, not recruitingOBSERVATIONAL
Enrollment

579

Participants

Timeline

Start Date

August 14, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Hepatocellular Carcinoma
Trial Locations (4)

100

National Taiwan University Hospital, Taipei

Unknown

National Cheng-Kung University Hospital, Tainan City

Mackay Memorial Hospital, Taipei

National Taiwan University Cancer Center, Taipei

All Listed Sponsors
collaborator

National Taiwan University Hospital

OTHER

collaborator

Mackay Memorial Hospital

OTHER

collaborator

National Cheng-Kung University Hospital

OTHER

lead

National Health Research Institutes, Taiwan

OTHER